Navigation Links
Gladstone founder receives American Heart Association Distinguished Scientist Award
Date:11/14/2011

SAN FRANCISCO, CANovember 15, 2011The American Heart Association will today present Gladstone Institutes Senior Investigator and President Emeritus Robert Mahley, MD, PhD, with the 2011 AHA Distinguished Scientist Award, bestowing yet another honor on one of Gladstone's founding cardiovascular scientists.

The Distinguished Scientist Award is the highest honor that the American Heart Association can give a scientist. Dr. Mahley is one of just five scientists this yearand the first from Gladstoneto receive the award. He will receive the award today during the annual AHA Scientific Sessions in Orlando, Fla.

Dr. Mahley, who founded Gladstone in 1979 before serving as its president for 30 years, is an internationally recognized expert on heart disease, cholesterol metabolism and, more recently, Alzheimer's disease. Early in his career, Dr. Mahley discovered the existence of apoE, a protein that transports cholesterol and helps to regulate cholesterol levels in the blood. After his arrival at Gladstone, he developed an understanding of the critical role that apoE plays in heart disease. This, in turn, laid the groundwork for the explosion of research related to apoE4, a detrimental type of apoE that is found in 1 in 4 Americans. Today, many scientists believe that apoE4 is linked to brain-cell injury and the progression of Alzheimer's disease, a devastating neurodegenerative disease that is the sixth leading cause of death in the United States.

"Dr. Mahley has long been an exemplar of excellence in cardiovascular research," said Dr. Garret FitzGerald, chair of the American Heart Association's Distinguished Scientists Selection Committee. "His penetrating insights and discoveries around apoE have shaped the field, influencing research in both cardiovascular biology and neurodegenerative disease. He is well deserving of this prestigious and exclusive award."

The American Heart Association, an organization that is committed to re
'/>"/>

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534
Gladstone Institutes
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Gladstone scientists reveal that fat synthesizing enzyme is key to healthy skin and hair
2. Gladstone scientists reveal key enzyme in fat absorption
3. Gladstone scientists identify key factors in heart cell creation
4. Gladstones Shinya Yamanaka wins Lasker Award
5. Gladstone and Institute for Systems Biology collaborate on Huntingtons disease
6. Gladstones Shinya Yamanaka wins Kyoto prize
7. Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells
8. Gladstone scientists uncover mechanism for the major genetic risk factor of Alzheimers disease
9. Gladstone scientists identify genes involved in embryonic heart development
10. Gladstone to receive $5.6 million in federal funds to seek a cure for AIDS
11. Gladstone scientists offer new insight into the regulation of stem cells and cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gladstone founder receives American Heart Association Distinguished Scientist Award
(Date:12/10/2014)... -- You,ve been here before: you desperately need to sign ... site key or the answer to your secret question. What,s ... Today, Hoyos Labs , a digital infrastructure ... put an end to the frustration that comes with usernames, ... leverages a user,s smartphone to acquire his or her biometrics ...
(Date:12/10/2014)... Dec. 9, 2014 CIE San Diego has ... provides the connective tissue that enhances care coordination among ... easily share client-level information; earned a second $1 million ... organizations serving seniors aging in community and; will be ... December 11 th 4-6p. CIE San ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... created a bio patch to regenerate missing or damaged ... delivers bone-producing instructions directly into cells. The bone-regeneration ... containing the genes needed for producing bone. In experiments, ... to cover skull wounds in test animals. It also ...
... to Canada,s fisheries legislation "have eviscerated" the ability ... fish species, scientists at the University of Calgary ... The changes were "politically motivated," unsupported by ... and are inconsistent with ecosystem-based management, fisheries biologists ...
... Catherine Pickering, said the Griffith study looked at the ... dispersed through horse manure. The findings have been published ... "We reviewed 15 studies on seed germination from ... three from Australia and one study each from Africa ...
Cached Biology News:A bio patch that can regrow bone 2A bio patch that can regrow bone 3Changes to fisheries legislation have removed habitat protection for most fish species in Canada 2Saddling up against the threat to our National Parks 2
(Date:12/17/2014)... (PRWEB) December 16, 2014 The ... since 2013, which is why IBISWorld updated its original ... continues to benefit from an intensified focus on environmental ... for new emission standards for power plants and a ... According to IBISWorld Industry Analyst Sarah Kahn, “a range ...
(Date:12/17/2014)... Washington, USA (PRWEB) December 16, 2014 ... Baum, manager at Philipps- Universität Marburg’s Department of ... and photonics, in the newly released SPIE ... “And never be too shy to ask questions.” ... (science, technology, engineering, and mathematics) occupations ranging from ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... This report is a professional and ... an overview analysis, the report introduces quartz tubing ... industry overview, policy analysis, and news analysis, etc. ... witnessed rapid development with key manufacturers increasing their ... mentions quartz tubing upstream raw materials and equipment, ...
Breaking Biology Technology:Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 82020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2
... Systems , a leading Microsoft IT consulting firm ... 2010 and FAST implementation for Array BioPharma, a biopharmaceutical ... targeted small molecule drugs to treat patients afflicted with ... year, Array conducted a proof of concept (POC) with ...
... Texas, Nov. 5, 2010 Lexicon Pharmaceuticals, Inc. ... focused on discovering breakthrough treatments for human disease, today ... reported financial results for the three and nine months ... proof-of-concept for two new mechanisms of action in irritable ...
... Project on Emerging Nanotechnologies (PEN) at the Woodrow ... of voluntary options available for the oversight of ... Initiatives, Regulation, and Nanotechnology Oversight: Charting a Path, ... for Environmental Policy at American University, provides a ...
Cached Biology Technology:Catapult Systems Awarded SharePoint 2010 and FAST Intranet Project 2Catapult Systems Awarded SharePoint 2010 and FAST Intranet Project 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 2Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 3Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 4Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 5Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 6Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Third Quarter Financial Results 7
... of siRNA while maintaining high cell viability ... samples simultaneously , Fast: less ... post-electroporation incubation , Highly reproducible ... for use with the Bio-Rad Gene Pulser ...
Mouse CXCR3 Allophycocyanin MAb (Clone 220803)...
Request Info...
Recombinant Rat Leptin, Ultra Pure...
Biology Products: